School project · Delayed data · Not financial adviceTerms
SingularityViewAll companies

Stock research

Cryo-Cell International Inc CCEL

Healthcare · Health Care

$4.36last close 2026-10-09 · market cap $35.15M · delayed data

Trailing returns

1M+6.08%
3M+23.16%
6M+17.84%
1Y-1.36%
5Y-54.70%

Basis: Adjusted daily closes.

What it does

Cryo-Cell International, Inc. engages in cord blood and cord tissue cryopreservation services in the United States. The company offers cellular processing and cryogenic storage for family use, primarily for collection and preservation of umbilical cord blood, and tissue stem cells; and cellular processing and cryogenic storage of umbilical cord blood stem cells for public use.

Open CCEL in the live terminal →

Valuation, cost of capital, SEC filings, ownership and more, with the source named on every figure.

Post on XLinkedInEmail

Where these figures come from

Delayed data. Not financial advice. Figures are read from the sources above at the dates shown; nothing here is a recommendation. Disclosures · All companies